Navigation Links
Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
Date:12/4/2010

Poster III  
  • Date: Monday, December 6, 6:00 - 8:00 p.m. ET
  • Location: Hall A3/A4 (Orange County Convention Center)
  • Poster Board III-383

  • Sub-Optimal Inhibition of Thrombus Formation by Aspirin (as measured by RTTP analysis) in Primary Thrombocythemia

    • Presenter: Gillian Stephens, Ph.D., Portola Pharmaceuticals
    • Poster Session: Pathophysiology of Thrombosis: Poster II
    • Date: Monday, December 6, 6:00 - 8:00 p.m. ET
    • Location: Hall A3/A4 (Orange County Convention Center)
    • Poster Board III-997

    About Portola Pharmaceuticals, Inc.

    Portola Pharmaceuticals develops innovative therapeutics based on targets with established proofs of concept that are designed to provide significant advances over current treatments for cardiovascular disease and inflammation. The company has global development and commercialization agreements with two of the world's leading pharmaceutical companies collectively valued at about $1 billion in upfront and milestone payments plus double-digit royalties on future sales. Betrixaban, its oral direct Factor Xa inhibitor, is licensed to Merck & Co., Inc., and elinogrel, its competitive, reversible direct-acting i.v. and oral P2Y12 ADP receptor antagonist, is licensed to Novartis Pharma AG. Both are Phase 2 product candidates that have best-in-class features to address the global multi-billion dollar hospital, specialty and chronic care antiplatelet and anticoagulant markets.

    Portola's proprietary pipeline programs are focused on the discovery and development of PRT064445, a novel recombinant protein anticoagulant antidote, known as the Factor Xa inhibitor antidote, to help manage or reverse the bleeding complications in the tens of millions of patients expected to be treated with Factor Xa inhibitors or low-molecular weight heparin worldwide in
    '/>"/>

    SOURCE Portola Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
    2. Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
    3. Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders
    4. Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
    5. Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
    6. Neuraltus Pharmaceuticals Reports Clinical Results from Phase 1/2 NP002 Study in the Treatment of Dyskinesias Resulting from Levodopa Therapy for Parkinsons Disease
    7. Access Pharmaceuticals Updates MuGard Website With First Patient Testimonial Video
    8. Sagent Pharmaceuticals Adds to Its Oncology Portfolio With Launch of Topotecan Hydrochloride for Injection
    9. Sagent Pharmaceuticals Announces FDA Approval of Midazolam Injection, USP
    10. Inspiration Biopharmaceuticals Treats First Patient in Pivotal Study of OBI-1 for Acquired Hemophilia A
    11. Onyx Pharmaceuticals Announces December 2010 Investor Events
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2014)... NEW YORK , Aug. 27, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p02316641/Global-Animal-Health-Market-2014-2018.html About Animal Health ... prevent animal diseases or treat animals to enhance ... increase the yield of animal food. The Global ...
    (Date:8/27/2014)... N.C. , Aug. 27, 2014 Kewaunee ... its Board of Directors increased its quarterly cash dividend ... eleven cents per outstanding share, beginning with the dividend ... at the close of business on September 8, 2014. ... Founded in 1906, Kewaunee Scientific Corporation is a ...
    (Date:8/27/2014)... 2014  UBM Medica US announces that ... medical imaging professionals, presents special reporting about diagnostic imaging ... 2014 Annual Meeting . Among the ... 11 Principles of Successful Labor Management in Radiology ... , Why Don,t Patients Know the Truth ...
    Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
    (Date:8/27/2014)... Spine Guide has built a reputation for ... spinal health. Now, the e-health site will offer new ... back pain symptoms. Spine Guide specializes in three types ... spine surgery. , Some of the most common back ... pain radiating down the leg, inability to stand up ...
    (Date:8/27/2014)... Beach, Florida (PRWEB) August 28, 2014 ... Kevin Harrington, Chairman of As Seen On TV, Inc., ... as “The Millionaire Maker”. as Excelerate attendees will learn ... and will have the ability to pitch to an ... World Renowned Business Experts and Millionaire Mentors directly to ...
    (Date:8/27/2014)... When it comes to the bedroom, most homeowners want ... breaking the bank in the process. Regardless of whether individuals ... for the master bedroom or simply looking for something inexpensive ... during their Labor Day mattress promotion. , This Labor ... for the home, while enjoying free delivery. Beyond bringing the ...
    (Date:8/27/2014)... San Diego, CA (PRWEB) August 27, 2014 ... homeowner insurance policies will now be easier for the ... home insurance prices that are promoted in all 50 ... http://quotespros.com/homeowners-insurance.html . , The different insurers that are ... have made it possible for adults to use the ...
    (Date:8/27/2014)... August 27, 2014 Locating an approximate ... consumer to present personal information before rates would be ... that life insurance quotes are distributed online using its ... term plans that an adult has access to review ... U.S. companies. The system for quotation distribution built in ...
    Breaking Medicine News(10 mins):Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Life Insurance Quotes for Term Policies Now Found at Insurer Website Online 2
    ... Aug. 8 (HealthDay News) -- The most effective treatment for ... the continuous positive airway pressure (CPAP) machine, according to a ... mask while the patient sleeps. This treatment is highly effective ... according to the review of available evidence. However, side ...
    ... By Amanda Gardner HealthDay Reporter , MONDAY, Aug. ... who has cardiac catheterization to diagnose heart disease is found ... But in other hospitals, relatively few are found to have ... patients may be getting unnecessary procedures, according to a study ...
    ... (August 8, 2011) The use of Acute Care Emergency ... significant reductions in key patient measures, such as length of ... ED overcrowding), according to a study published in the August ... Surgeons . Emergency departments are a crucial point of access ...
    ... Prenatal pet exposure, a mother,s delivery mode and race are ... 2, according to a Henry Ford Hospital study. In a ... researchers found that babies who have indoor prenatal pet exposure have ... IgE, between birth and age 2. IgE is linked to the ...
    ... -- The discovery of a gene pattern that distinguishes highly ... may help improve treatment of bone cancer in children, according ... species that develops bone cancer spontaneously with any frequency. Dogs ... human and dog forms of bone cancer are very similar, ...
    ... have radical surgery at university hospitals can benefit from excellent ... death rates, according to research in the August issue of ... 2,287 patients who had radical cystectomy surgery, where the bladder ... The surgery was performed at eight Canadian academic centres between ...
    Cached Medicine News:Health News:CPAP Therapy Most Effective for Sleep Apnea, Experts Say 2Health News:CPAP Therapy Most Effective for Sleep Apnea, Experts Say 3Health News:Hospitals Vary Widely in Rate of Heart Procedures: Study 2Health News:Hospitals Vary Widely in Rate of Heart Procedures: Study 3Health News:Urgent assessment in emergency departments can reduce surgical decision time and overcrowding 2Health News:Prenatal pet exposure, delivery mode, race are key factors in early allergy risk 2Health News:Study of Bone Cancer in Dogs May Improve Treatment in Kids 2Health News:Improved radical surgery techniques provide positive outcomes for bladder cancer patients 2
    ... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
    ... GonoGen™ is a monoclonal ... for the confirmatory identification of ... not require isolated, viable or ... specimen and two minute rotation, ...
    Rapid Test Kit...
    ... a novel device for the growth ... and Neisseria meningitidis. This product ... is easily transportable as a self-contained ... and examine the growth of organisms ...
    Medicine Products: